| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a9614cb01a5dfed48e25c7018c9b89b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640fed18784a3e5cd9526ce755a4815a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b428cb1fd4e07eb617f02a7eaba3bd55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80ace24ba4c7678368563b64d8d29dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951bff24458eb6ffca2558514454b06d |
| publicationDate |
1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1301172-C |
| titleOfInvention |
Thianaphthene derivatives, their production and use |
| abstract |
ABSTRACT Compounds of formula (I): (I) (wherein n is 0 or 1, R1 and R2 are hydrogen or alkyl, one of A1 and A2 is -Z-Y and the other is -W-COOH, where W and Z are alkenylene or alkylene and Y is imidazolyl or pyridyl, and the broken lines represent two single bonds or one single bond and one double bond) and their salts, esters and amides have the ability to inhibit the synthesis of thromboxane A2 and hence are useful in the treatment or prophylaxis of thrombotic conditions. They may be prepared by introducing an imidazolyl or pyridyl group into the corresponding compound in which Y is replaced by an active group or atom. |
| priorityDate |
1986-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |